We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, such as primary biliary cirrhosis, utilizing our expertise in bile acid chemistry. Our product candidates have the potential to treat orphan and more prevalent liver diseases for which there currently are limited therapeutic solutions.
Upcoming Events
There are currently no upcoming events.